BIOMAT Database Logo BIOMAT Database Logo

Leukemia inhibitory factor relaxes arteries through endothelium-dependent mechanism. 2002

Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Department of Cadiovascular Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama 641-8510, Japan. kimura@wakayama-med.ac.jp

Leukemia inhibitory factor (LIF) is a cytokine, which inhibits angiogenesis and decreases endothelial cell proliferation and migration, suggesting that LIF may modulate vascular tone. In this study, we examined the effects of LIF on the tone of rat arteries. The isometric tension of ring preparations from rat superior mesenteric arteries was continuously measured. LIF relaxed the mesenteric arteries in a dose-dependent manner, when the arterial rings were precontracted with phenylephrine. The relaxation was totally inhibited by mechanical removal of endothelium. N(G)-nitro-L-arginine methyl ester did not affect the relaxation by LIF. Ca(2+)-dependent K channel (KCa) blockers, apamin with charybdotoxin, inhibited the relaxation by LIF. Catalase, an enzyme which scavenges hydrogen peroxide, also inhibited the relaxation by LIF. Endothelium-derived hyperpolarizing factor relaxes smooth muscle cells and the effect is blocked by KCa and catalase. Our results suggest that LIF regulates vascular tone through the effect of this factor.

UI MeSH Term Description Entries
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008297 Male Males
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006131 Growth Inhibitors Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth ( Cell Growth Inhibitor,Cell Growth Inhibitors,Growth Inhibitor,Growth Inhibitor, Cell,Growth Inhibitors, Cell,Inhibitor, Cell Growth,Inhibitor, Growth,Inhibitors, Cell Growth,Inhibitors, Growth
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines

Related Publications

Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Irisin relaxes mouse mesenteric arteries through endothelium-dependent and endothelium-independent mechanisms.
December 2015, Biochemical and biophysical research communications,
Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Nuciferine relaxes rat mesenteric arteries through endothelium-dependent and -independent mechanisms.
December 2015, British journal of pharmacology,
Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms.
May 1995, Coronary artery disease,
Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Calcitonin gene-related peptide relaxes porcine arteries via one endothelium-dependent and one endothelium-independent mechanism.
February 1991, Acta physiologica Scandinavica,
Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism.
November 2000, The Journal of pharmacology and experimental therapeutics,
Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism.
November 1995, Circulation research,
Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism.
February 2005, Regulatory peptides,
Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Formononetin, an isoflavone, relaxes rat isolated aorta through endothelium-dependent and endothelium-independent pathways.
July 2010, The Journal of nutritional biochemistry,
Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism.
June 1999, Journal of vascular surgery,
Keizo Kimura, and Kazushi Tsuda, and Chizu Moriwaki, and Tetsuya Kawabe, and Masanori Hamada, and Masahiro Obana, and Akira Baba, and Takuzo Hano, and Ichiro Nishio
Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation.
December 1992, Circulation research,
Copied contents to your clipboard!